Crispr Therapeutics shares owned by Greenwood Capital Associates
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Greenwood Capital Associates
from 13F filings
Historical chart of Greenwood Capital Associates investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Greenwood Capital Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Greenwood Capital Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $327k | 7.0k | 46.98 |
| 2024-06-30 | $385k | 7.1k | 54.01 |
| 2024-03-31 | $456k | 6.7k | 68.16 |
| 2023-12-31 | $426k | 6.8k | 62.60 |
| 2023-09-30 | $249k | 5.5k | 45.39 |
| 2023-06-30 | $307k | 5.5k | 56.14 |
| 2023-03-31 | $255k | 5.6k | 45.23 |
| 2022-12-31 | $2.6M | 65k | 40.65 |
| 2022-09-30 | $3.9M | 60k | 65.36 |
More positions owned by Greenwood Capital Associates
View all positions for Greenwood Capital Associates